42 43 44 45 and may provide a readily accessible indicator of several diseases of vascular origin. We report 46 a meta-analysis of genome-wide association studies (GWAS) for quantitative retinal vascular 47 traits derived using semi-automatic image analysis of digital retinal photographs from the 48 GoDARTS (n=1736) and ORCADES (n=1358) cohorts. We identified a novel genome-wide 49 significant locus at 19q13 (ACTN4/CAPN12) for retinal venular tortuosity, and one at 13q34 50 (COL4A2) for retinal arteriolar tortuosity; these two loci were subsequently confirmed in three 51 independent cohorts. In the combined analysis, the lead SNP at each locus was rs1808382 in 52 ACTN4/CAPN12 (P=2.39×10 -13 ) and rs7991229 in COL4A2 (P=4.66×10 -12 ). Notably, the 53 ACTN4/CAPN12 locus associated with retinal venular tortuosity traits is also associated with 54 coronary artery disease and heart rate. Our findings demonstrate the contribution of genetics in 55 retinal vascular traits, and provide new insights into vascular diseases. 56 Retinal vascular traits can be readily measured non-invasively from fundus images and have been 57 linked to a number of clinical conditions associated with vascular health 1 including diabetes mellitus 2 , 58 stroke 3 , cardiovascular disease 4,5 , hypertension 6 , and neurodegenerative disease 7,8 . Understanding the 59 genetic determinants of retinal vascular traits may contribute to greater understanding of molecular 60 mechanisms involved in determining disease risks and progression. Recent genome-wide association 61 studies (GWAS) reported loci for widely investigated retinal traits including the central retinal vein 62 equivalent (CRVE) 9-11 and the retinal arteriolar equivalent (CRAE) 10 , and optic disc morphology 12-15 .
(Poverall=1.95×10 -07 ). For TortV the lead SNPs maintained genome-wide significance rs1808382 110 (Poverall=2.39×10 -13 ), rs3786835 (Poverall=3.31×10 -13 ) near ACTN4/CAPN12 (Table 1) . These SNPs are 111 in tight LD and therefore do not represent independent signals. Regional plots and Forest plots for the terminal non-collagenous domains play a role in angiogenesis 27 . Several studies suggest that the 118 mutations in COL4A2 and (or) COL4A1 (a paralogue immediately proximal to COL4A2, with which 119 it shares a promoter and is co-expressed) cause a broad spectrum of diseases including retinopathy 28 , 120 glaucoma 28 , familial cerebrovascular, small vessel diseases 29 , and retinal hemorrhages 30 . In addition,
121
COL4A2 mutations in mice are associated with small vessel disease, intracerebral hemorrhage and 122 retinal changes 31 . Mendelian variants in COL4A1 underlie syndromes which include tortuous retinal 123 vessels 32 . Recent GWAS report that common variants around COL4A1 and COL4A2, are associated 124 with coronary artery calcification 33 , arterial stiffness 34 , and coronary artery disease [35] [36] [37] [38] (CAD) . 125 Interestingly, gene expression data from GeneAtlas 39 , a human protein-coding transcriptome study 126 validated the high expression of COL4A2 in retinal micro-vessel endothelial cells (Supplementary 127 Figure 6 ) whereas COL4A1 is weakly expressed in retina and this supports the specific role of COL4A2 128 in the retinal vasculature. Genome-wide significant TortA-associated variants near COL4A2 129 significantly alter the transcription factor binding motifs, overlap enhancer histone marks and have 130 putative effects on transcription as annotated by the ENCODE ( Supplementary Table 6 ).
ACTN4 encodes alpha-actinin 4, a cross-linking protein belonging to the spectrin superfamily; 143 mutations in this gene cause focal segmental glomerulosclerosis in humans 41 . ACTN2, a homolog of 144 ACTN4, interacts with ACTN4 and missense mutations in ACTN2 are linked to a range of cardiac 145 diseases 42 . Annotation by ENCODE 43 indicates that the two genome-wide significant variants 146 (rs1808382, rs3786835) associated with TortV near ACTN4 may have direct regulatory effects as they 147 are located within a DNase I hypersensitivity site in multiple cell types and are located in genomic 148 regions enriched for promoter/enhancer histone marks especially in heart tissues (Supplementary 149   Table 6 ). ACTN4 overlaps with CAPN12 (calcium-activated neural proteases) by 339 bases at their 3' 150 ends and multi-tissue expression quantitative trait loci (eQTL) analysis confirms that these SNPs in 151 ACTN4 are associated with mRNA expression of both ACTN4 and CAPN12 in aorta, tibial artery, atrial 152 appendage and left ventricle of the heart ( Supplementary Table 7 , Supplementary Figure 9 ). 153 Additionally, this analysis indicates that the T allele at rs1808382 is correlated with lower ACTN4 154 (artery aorta; P=2.1×10 -03 ) and this correlation is even stronger with CAPN12 (artery aorta; P=2.0×10 -155 07 ). However, while gene expression data using GENEINVESTIGATOR validated the high expression 156 of ACTN4 in arterial tissue, the highest expression of CAPN12 appears to be in the hematopoietic 157 system. Furthermore, lead SNPs in ACTN4 are significantly associated with coronary artery disease in 158 the CARDIoGRAMplus C4D consortium meta-analysis 36 ( Supplementary Table 9 ) and are 159 associated with CAD risk factors; HDL cholesterol and triglycerides in the Global Lipid Genetics 160 Consortium analysis 44 ( Supplementary Table 11 ). Finally, recent meta-analysis of 35 GWAS studies 161 reported the association of SNP (rs11083475) in the ACTN4 locus with increased resting heart rate 45 162 which may increase cardiovascular disease risk. This signal is the same as that for TortV with strong 163 LD being observed between the lead SNPs for TortV and the index SNP for heart rate. Furthermore 164 we found that these SNPs are associated with heart rate in UK Biobank ( Supplementary Table 12 Arterioscler. Thromb. Vasc. Biol. 31, 1933 -1938 (2011 were used for the three independent GWAS analysis. Additional information on the characteristics of 467 both study cohorts and study design can be found in Supplementary Figure 1 and Table 1. were performed in SNPTEST v2.5 using the genome-wide associated loci in the COL4A2 region, 500 conditioned on lead SNPs (rs56399312). Also, this new locus was conditioned on previously reported Figure 2. Regional association and recombination plots of variants that reached genome-wide significance in overall meta-analysis (discovery and replication stage). Each plot was created using LocusZoom for the lead SNP in genomic region 400 kb in either side of the significant signal. Blue spikes represents the estimated recombination rates. Colour scale (high to low r2) circles depicts the pairwise correlation (r2) between lead SNP and other SNPs in the loci, and grey colour indicates that linkage disequilibrium (LD) information was not available in the reference population. The lead SNP in that region is indicated by purple colour solid diamond and gene annotations in this region is shown in the bottom panels. Chromosome, base position and SNPID information is based on NCBI build 37 and dbSNP138.
